Foresite Capital Management V, LLC
Related Filers (15)
- Foresite Capital Fund V, L.P. (22)
- Foresite Capital Opportunity Management V, LLC (14)
- Tananbaum James B. (14)
- Foresite Capital Opportunity Fund V, L.P. (14)
- PARDES BIOSCIENCES, INC. (9)
- Foresite Capital Management IV, LLC (7)
- Foresite Capital Fund IV, L.P. (7)
- Kinnate Biopharma Inc. (5)
- Gemini Therapeutics, Inc. /DE (3)
- FS Development Holdings, LLC (3)
- Theseus Pharmaceuticals, Inc. (3)
- FS Development Holdings II, LLC (3)
- Foresite Capital Management III, LLC (2)
- Aclaris Therapeutics, Inc. (2)
- Foresite Capital Fund III, L.P. (2)
- Show More ...
Other (13)
13F-HR
Tuesday, 2/13/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/11/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/12/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/12/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/13/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/11/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/12/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (22)
4
Thursday, 8/31/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/10/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/6/2023
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/22/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/3/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/5/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
3
Monday, 6/13/2022
Theseus Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4/A
Friday, 6/10/2022
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4/A
Thursday, 12/30/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/28/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/23/2021
PARDES BIOSCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
Aclaris Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/23/2021
FS Development Corp. II: Statement of changes in beneficial ownership of securities
3
Tuesday, 2/16/2021
FS Development Corp. II: Initial statement of beneficial ownership of securities
3
Wednesday, 2/10/2021
Aclaris Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 2/9/2021
Gemini Therapeutics, Inc. /DE: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 12/3/2020
Kinnate Biopharma Inc.: Initial statement of beneficial ownership of securities
4
Monday, 10/19/2020
FS Development Corp.: Statement of changes in beneficial ownership of securities
3/A
Wednesday, 8/19/2020
FS Development Corp.: Initial statement of beneficial ownership of securities